Technology | March 06, 2015

ACC Guideline App Upgrade Includes Full Set of Prevention Guidelines

App provides mobile access to guidelines, tools for treatment, heart disease prevention information

ACC, Guideline App, prevention, atrial fibrillation, clinical decision support

March 6, 2015 — The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full set of clinical prevention guidelines released by ACC/American Heart Association in 2013. These additions expand the collection of clinical guidelines in the app, which already includes guidelines on assessment of cardiovascular risk, treatment of blood cholesterol, atrial fibrillation, heart failure and valvular heart disease.

ACC’s Guideline Clinical App was developed to serve as a mobile home for all ACC/AHA guideline content and related tools. It includes an executive summary and top 10 points for each guideline, as well as a collection of interactive tools such as dosing calculators, scoring tools and algorithms useful to clinicians in determining recommended care

The original version of the app was launched in November 2014, with a second content release in December 2014. Version 2.0 of the app is part of a plan to continuously add guideline content, upgrade functionality and roll out fixes in response to user feedback. More guideline content and improvements are planned throughout 2015. ACC is conducting an impact and evaluation study to help inform future plans for the app. 

The ACC Guideline Clinical App is available for free and can be downloaded to a tablet or smartphone from iTunes and GooglePlay. 

For more information: www.acc.org


Related Content

News | Atrial Fibrillation

Feb. 14, 2025 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home February 14, 2025
Home
News | Atrial Fibrillation

Feb. 12, 2025 — On Feb. 11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., cardiac electrophysiologist ...

Home February 12, 2025
Home
News | Atrial Fibrillation

Jan. 16, 2025 — Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac ...

Home January 29, 2025
Home
News | Atrial Fibrillation

Jan. 22, 2025 – Anthos Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat ...

Home January 24, 2025
Home
News | Atrial Fibrillation

Dec. 19, 2024 — Drinking multiple cups of coffee a day may help prevent cognitive decline in people with atrial ...

Home December 19, 2024
Home
News | Atrial Fibrillation

Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...

Home November 19, 2024
Home
News | Atrial Fibrillation

Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm ...

Home October 21, 2024
Home
News | Atrial Fibrillation

Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San ...

Home September 11, 2024
Home
News | Atrial Fibrillation

July 24, 2024 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
News | Atrial Fibrillation

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
Subscribe Now